[1] Kearney PM, Whelton M, Reynolds K,et al. Global bur-den of hypertension: analysis of worldwide data [J]. Lan-cet, 2005,365(9455):217-223. [2] Forouzanfar MH, Liu P, Roth GA,et al. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg,1990-2015 [J]. JAMA, 2017,317(2): 165-182. [3] GBD2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study2017[J]. Lancet,2018,392(10159):1684-1735. [4] Zanchetti A, Thomopoulos C, Parati G, et al. Random-ized controlled trials of blood pressure lowering in hyper-tension: a critical reappraisa [J]. Circ Res, 2015,116(6): 1058-73. [5] Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet,2019,pii:S0140-6736(19)30427-30431. [6] Zhao Y, Hu Y, Smith JP,et al. Cohort profile: the China health and retirement longitudinal study (CHARLS) [J]. Int J Epidemiol, 2014,43(1):61-8. [7] Wang Z, Chen Z, Zhang L,et al. Status of Hypertension in China: Results from the China Hypertension Survey, 2012-2015[J]. Circulation, 2018,137(22):2344-2356. [8] Irazola VE, Gutierrez L, Bloomfield G, et al. Hyperten-sion Prevalence, Awareness, Treatment, and Control in Selected LMIC Communities: Results From the NHLBI/ UHG Network of Centers of Excellence for Chronic Dis-eases [J]. Glob Heart, 2016,11(1):47-59. [9] 刘力生.中国高血压防治指南2010[J].中华高血压杂志,2011,19 (8):701-743. [10] Lu J, Lu Y, Wang X,etal. Prevalence, awareness, treat-ment, and control of hypertension in China: data from1·7 million adults in a population-based screening study (China PEACE Million Persons Project) [J]. Lancet, 2017,390 (10112):2549-2558. [11] 张艳妮,曾繁慧,包研科,等.辽宁省阜新农村地区人群高血压危 险因素分析[J].中华高血压杂志,2017,25(10):937-941. [12] 田爱红,田蕊,张润华,等.北京市石景山社区居民高血压知晓率、 治疗率和控制率及影响因素的相关研究[J].中国卒中杂志,2017, 12(9):794-799.[13] 宓伟,尹淑英,练武,等.烟台市农村老年人高血压知晓率、治疗率 和控制率的现状及其影响因素[J].中国老年学杂志,2015,35(21): 6220-6222. [14] Dastan I, Erem A, Cetinkaya V. Awareness, treatment, control of hypertension, and associated factors: Results from a Turkish national study [J]. Clin Exp Hypertens, 2018,40(1):90-98. [15] 张丹薇,崔建兰,吴超群,等.我国西南地区年龄35~75岁成人高血压 知晓、治疗和控制现状[J].中华高血压杂志,2019,27(3):235-241. [16] Mohamed SF, Mutua MK, Wamai R,et al. Prevalence, awareness, treatment and control of hypertension and their determinants: results from a national survey in Kenya [J]. BMC public health,2018,18(Suppl 3). [17] Morris AB, Li J, Kroenke K,et al. Factors associat-ed with drug adherence and blood pressure control in pa-tients with hypertension [J]. Pharmacotherapy, 2006,26(4): 483-492. [18] DiMatteo MR. Social support and patient adherence to medical treatment: a meta- analysis [J]. Health Psychol, 2004,23(2):207-218. [19] Lloyd- Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and con-trol in the community [J]. JAMA, 2005(294):466-472. [20] Nguyen QT, Anderson SR, Sanders L,etal. Managing hy-pertension in the elderly: a common chronic disease with in-creasing age [J]. Am Health Drug Benefts,2012(5):146-153.